Le-Quoc Alexis Reports Major Stock Transactions at Datadog
Le-Quoc Alexis discloses significant stock transactions involving Datadog's Class A and B shares, reflecting active management of equity stakes.
Vertical Data Inc. Reports Director Stock Transactions
Vertical Data Inc. discloses stock transactions by director Jaime Leverton, reflecting ongoing activity in the management consulting services sector.
Creatura Christopher Reports Multiple Stock Transactions
Creatura Christopher discloses several stock transactions, reflecting his ongoing commitment to Vertical Data Inc. and the management consulting services industry.
Vertical Data grants RSUs to director David Hackett
Vertical Data Inc. grants restricted stock units to director David Hackett, reinforcing its commitment to leadership incentives in the management consulting sector.
Gordon Craig D amends Form 4 on Pyxis Oncology warrants
Gordon Craig D amends Form 4 to correct Common Stock Purchase Warrants for Pyxis Oncology, indicating ongoing investment activities.
Sweetnam Paul Reports Significant Stock Transactions
Sweetnam Paul, Chief Scientific Officer at Retension Pharmaceuticals, reports significant stock transactions in a recent SEC filing.
Retension Pharmaceuticals director reports significant stock moves
Retension Pharmaceuticals' director Franklin M. Berger reports key stock transactions, reflecting ongoing activity in the pharmaceutical preparations sector.
Retension Pharmaceuticals director reports stock transactions
Retension Pharmaceuticals, Inc. director Michael J. Berendt disclosed stock transactions in a recent SEC filing, indicating ongoing developments in the company.
Retension Pharmaceuticals CEO Eric L. Keller Reports Stock Moves
Eric L. Keller, CEO of Retension Pharmaceuticals, reports significant stock transactions, acquiring over 208,000 shares, reflecting confidence in the company's future.
Retension Pharmaceuticals director acquires 5,637 shares
Retension Pharmaceuticals' director, Donald Olds, acquires 5,637 shares of common stock, reflecting ongoing engagement in the pharmaceutical sector.
Innovative Industrial Properties Executes Preferred Stock Purchase
Innovative Industrial Properties Inc. has completed a significant transaction involving its Series B Preferred Stock, signaling a strategic move in the real estate sector.
Zoom CEO Eric S. Yuan Reports Significant Stock Transactions
Eric S. Yuan, CEO of Zoom, disclosed important stock transactions in a recent SEC filing, reflecting his ongoing commitment to the company.
OGP VIII, LLC Reports Major Stock Transactions in Accelevation
OGP VIII, LLC has reported significant stock transactions in Accelevation Holdings Corp., indicating increased confidence in the electrical industrial apparatus sector.
Saba Capital Management Disposes of Shares in BlackRock ESG Trust
Saba Capital Management reports significant stock transactions in BlackRock ESG Capital Allocation Term Trust, holding over 12.4 million shares.
Peter Pieraccini acquires 50,000 stock options at Vogenx
Peter Pieraccini has acquired 50,000 stock options in Vogenx, Inc., emphasizing confidence in the company's future and its role in the pharmaceutical industry.
Accelevation Holdings director buys 7,000 shares of stock
Accelevation Holdings Corp. director Paul D. Donahue purchases 7,000 shares of Class A common stock, signaling confidence in the company's future.
Accelevation Holdings director purchases 10,000 shares
Director Ginger M. Jones of Accelevation Holdings Corp. acquires 10,000 shares at $18 each, signaling confidence in the company's future.
Accelevation Holdings COO Reports Significant Stock Transactions
Accelevation Holdings Corp. COO Jewell Brent C. reports major stock transactions, signaling growth in the electrical industrial apparatus sector.
Chafey Diana Reports Stock Transactions at Hagerty, Inc.
Chafey Diana, Chief Legal Officer at Hagerty, Inc., disclosed stock transactions, indicating ongoing engagement with the company's equity and confidence in its future.
Houston Andrew reports stock transactions in SEC filing
Houston Andrew details stock transactions in SEC filing, reflecting strategic moves within the company and potential industry impacts.